Kyoto Huakang Pharmaceutical Company!

Located in the southeast of Kyoto, the factory covers an area of ​​more than 100,000 square meters and has nearly 5,000 employees!

In Kyoto where every inch of land is valuable, having such a large factory is enough to show the strength of Huakang Pharmaceutical Company!

The entire factory is in a positive direction, with a six-story U-shaped factory building connected to the south, west and north!

In the inconspicuous corner to the east of the factory, there is a two-story white house, covering an area of ​​about 200 square meters. However, it spends all the profits of the entire factory every year!

It is Huakang Pharmaceutical Company, which established a laboratory for developing anti-cancer drugs three years ago!

The laboratory has a lot of medical equipment, all imported from abroad, and is of great value!

There are a total of 11 medical R&D technicians in the laboratory. They can be said to be the top talents in Longguo’s research and development of anti-cancer drugs!

In a laboratory on the second floor, a young technician whispered to their chief technical engineer Song Zhe.

"General Engineer Song, I heard that the company has problems and may go bankrupt!"

Song Zhe ignored it and was already doing the experiment!

Seeing that Chief Executive Song didn't say anything, the assistant had to shut up!

Until Song Zhe completed a drug molecule experiment in his hand!

After waiting for about five minutes, the results of the experiment came out!

He frowned slightly, and it was obvious that he had failed again!

In the past three years, their team has conducted at least 12,000 drug molecular experiments, and all failed without exception!

The general process of developing anti-cancer targeted drugs is divided into three steps!

1. Determination of targets and drug molecules. Targets refer to specific molecules that act in the body and achieve therapeutic effects. Drug molecules need to be screened in tens of thousands or hundreds of thousands of molecules. Is it very large and the failure rate is very high?

2. Preclinical research, after confirming the drug molecule, internal and external experiments are required. If it fails, it is necessary to continue screening the drug molecule from scratch!

3. Clinical research, this step not only costs money, but also has a very poor study time, usually several months to several years. By this step, there is a great failure rate.

In short, the development of anti-cancer targeted drugs has a long cycle and a low success rate, which is particularly expensive. On average, a new drug has been developed to market by about 10 billion.

Song Zhe and his colleagues' laboratory achieved the success of screening out two drug molecules, but they failed in both preclinical and clinical experiments, and finally they had to return to the first stage to re-screen drug molecules.

Song Zhe made a cup of coffee and took a break. He needed to enter the next drug molecule experiment later!

Song Zhe's assistant sorted out his experience in the experiment results and walked over to say!

"General Manager Song, don't believe it. My news is very reliable. The high-technician in our laboratory has found a foreign drug research and development company!"

Song Zhe's thoughts were interrupted by his assistant Liu Li, so he said angrily!

"Xiao Liu, where did you hear the rumor!"

When Liu Li saw Song Zhe speaking, she suddenly felt energetic and said with a mysterious look on her face!

"General Manager Song, this is not a rumor. My uncle is the financial director of our Huakang Pharmaceutical Company. I overheard..."

He knew that Liu Li's uncle was a financial director at Huakang Pharmaceutical Company, otherwise it would be impossible for Liu Li to come to the drug laboratory to be his assistant!

But Song Zhe did not think the news was true.

Huakang Pharmaceuticals is mainly engaged in the production of antibiotics. Three years ago, the boss found him and said he would develop anti-cancer targeted drugs!

In order to make Song Zhe join the R&D team wholeheartedly, he showed him the company's financial statements, with an annual profit of up to 2 billion!

Moreover, the boss Ren Dayuan also promised Song Zhe that he would only focus on research and development, and that Huakang Pharmaceutical Company would be enough to support his ten years of research!

Song Zhe agreed hesitantly. He believed that within ten years, he would definitely be able to develop anti-cancer drugs!

"General Manager Liu, I suggest you find a new home as soon as possible, otherwise you will be unemployed by then!"

"Xiao Liu, I think you are just idle. Go and prepare the experimental device. I am now preparing to do the experiment!"

Seeing that Song Zhe didn't believe him, Liu Li had no choice but to get up to sort out the experimental equipment!

Song Zhe took a break for about five minutes and then continued to work on the experiment!

Huakang Pharmaceutical Company Boss Office!

At this time, the boss Ren Dayuan looked sad.

The marketing manager sat opposite him and said angrily!

"These companies are so insidious. Seeing that our capital chain is broken, they actually united and killed us!"

"Hey! The mall is like a battlefield!"

Ren Dayuan sighed helplessly!

"Mr. Ren, we really shouldn't have been engaged in the research and development of anti-cancer drugs. We spent 6 billion yuan in three years, so we wouldn't be facing such a crisis!"

The reason why Ren Dayuan decided to develop anti-cancer drugs was that he saw that many people in the Dragon Kingdom could not afford to use imported anti-cancer drugs at all.

That's why he ignored Biren's opposition and resolutely wanted to develop Longguo's own anti-cancer drug!

In the past three years, Huakang Pharmaceutical Company has invested all its profits in the research of anti-cancer targeted drugs!

It turns out that the antibiotics of Huakang Pharmaceutical Company account for one-half of the entire Long Country's market, and there is no problem supporting a laboratory!

But in the past two years, many pharmaceutical companies that produce antibiotics have risen, and the competition between companies has led to a serious decline in their business volume!

Now their business volume accounts for less than 10% of the market share!

Coupled with the significant decline in profits today, their capital chain is directly broken!
Chapter completed!